&nbsp;

Biosimilar-Biologics.png

New

Jan 2025

Drug

bevacizumab

Other Name(s): Avastin® , Mvasi®; Zirabev®; Bambevi®; Abevmy®; Aybintio®; Vegzelma™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Nov 2024

Regimen

XELOX+PEMB

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma

ODB - General Benefit

capecitabine

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2025

Breast Cancer Screening for People at High Risk

Regimen

BINIENCO

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

binimetinib (Unfunded),

encorafenib (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Feb 2025

Drug

bortezomib

Other Name(s): Velcade®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Nov 2024

Regimen

XELOX+ZOLB

Cancer Type:

Gastrointestinal,

Gastric / Stomach

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Mar 2025

Regimen

BORTDEXALENA+DARA; LENA+DARA(MNT)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant

ODB - General Benefit

dexamethasone

Drugs Used:

daratumumab (Unfunded),

bortezomib (Unfunded),

lenalidomide (Unfunded),

dexamethasone

... Show more tags

Quick Link(s):

Regimen Monograph

Apr 2025

Document

Breast-Poster_English.zip

New

Apr 2025

Document

Breast-Poster_French.zip

New

Apr 2025

Document

Breast-Cancer-Screening-for-People-Ages-40-to-49_Arabic

New

Apr 2025

Document